Replies to post #55949 on Biotech Values

[DewDiligence]

>Biolex has something of a following in these circles.<

Hi, Erik. I’m not sure which circles you’re referring to. Do you mean Scandinavian biotech investors?

I’m interested in Biolex because they are a competitor of sorts to GTCB. Regards, Dew

[DewDiligence]

Biolex Pulls IPO

[Too bad—Biolex is an interesting company and it would’ve been easier to follow their progress in the transgenics arena if they had gone public.]

http://www.reuters.com/article/marketsNews/idUKN0146459120080201

>>
Fri Feb 1, 2008 5:48pm EST

WASHINGTON, Feb 1 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc on Friday canceled a planned initial public offering, citing market conditions.

The company, which had hired Lehman Brothers Inc. and Deutsche Bank Securities Inc to underwrite the IPO, notified the Securities and Exchange Commission of its plans to withdraw its IPO documents.
<<